The prostanoids in hemostasis and thrombosis: a review.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  American Journal of Pathology

• Publication date

  1980-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 6992594PMCID PMC1903705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet function and plasma free fatty acids during acute myocardial infarction and severe angina pectoris.

  2009cited by this paper
• Effects of acute myocardial ischaemia on platelet aggregation in the coronary sinus and aorta in dogs.

  2009cited by this paper
• PLATELET THROMBOSIS INDUCED BY ADENOSINE DIPHOSPHATE IN THE RAT.

  2009cited by this paper
• The influence of dietary fats on plasma and platelet lipids and ADP induced platelet thrombosis in the rat.

  2009cited by this paper
• The hemostatic effect of normal platelets in hemophilia and factor V deficiency. The importance of clotting factors adsorbed on platelets for normal hemostasis.

  2009cited by this paper
• The composition of food consumed by Greenland Eskimos.

  2009cited by this paper
• The tissue factor pathway of blood coagulation.

  1992cited by this paper
• Use of a radioimmunoassay to study thrombin-induced release of PGI2 from cultured endothelium.

  1979cited by this paper
• Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.

  1979cited by this paper
• Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's angina.

  1979cited by this paper
• Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence.

  1979cited by this paper
• Selective binding site for [3H]prostacyclin on platelets.

  1979cited by this paper
• Kinetic studies on the conversion of prostaglandin endoperoxide PGH2 by thromboxane synthase.

  1978cited by this paper
• Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes.

  1978cited by this paper
• Synthesis of prostaglandin H2 (PGH2) and prostacyclin (PGI2) analogs: tetrathia-PGH2 and PGI2-ketal methyl ester.

  1978cited by this paper
• Effect of various prostaglandins on the release of arachidonic acid from cultured fibroblasts.

  1978cited by this paper
• Fatty acids and the initial events of endothelial damage seen by scanning and transmission electron microscopy.

  1978cited by this paper
• COMPARISON OF THE VASODEPRESSOR EFFECTS OF PROSTACYCLIN AND 6‐OXO‐PROSTAGLANDIN F1α WITH THOSE OF PROSTAGLANDIN E2 IN RATS AND RABBITS

  1978cited by this paper
• An antiserum against 9,11-azo-15-hydroxy-prosta-5,13-dienoic acid recognises and binds prostaglandin endoperoxides

  1978cited by this paper
• The identification of trihydroxyeicosatrienoic acids as products from the incubation of arachidonic acid with washed blood platelets.

  1978cited by this paper
• Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187.

  1978cited by this paper
• Transformation of arachidonate into 6-oxoprostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 by sheep lung microsomal fraction.

  1978cited by this paper
• Generation of prostacyclin by lungs in vivo and its release into the arterial circulation

  1978cited by this paper
• Morphology of the early hemostasis in human skin wounds: influence of acetylsalicylic acid.

  1978cited by this paper
• PGI2 production by rat blood vessels: diminished prostacyclin formation in veins compared to arteries.

  1978cited by this paper
• Thromboxane synthase from bovine lung--solubilization and partial purification.

  1978cited by this paper
• Prostacyclin is a circulating hormone

  1978cited by this paper
• Biosynthesis of prostacyclin in rat liver endothelial cells and its control by prostaglandin E2

  1978cited by this paper
• Actions of prostaglandins on isolated perfused cat coronary arteries.

  1978cited by this paper
• Impairment of Platelet Thromboxane A2 Generation and of the Platelet Release Reaction in Two Patients with Congenital Deficiency of Platelet Cyclo‐oxygenase

  1978cited by this paper
• Different utilization of arachidonic and dihomogammalinolenic acids by human platelet prostaglandin synthetase.

  1978cited by this paper
• Further characterization of calcium-accumulating vesicles from human blood platelets.

  1978cited by this paper
• Chemotactic activity of thromboxane B2, prostaglandins and their metabolites for polymorphonuclear leucocytes.

  1978cited by this paper
• A comparison of imidazole and 9,11-azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors.

  1978cited by this paper
• Coronary-artery spasm.

  1978cited by this paper
• Synthesis of prostaglandin 6-keto F1alpha by cultured aortic smooth muscle cells and stimulation of its formation in a coupled system with platelet lysates.

  1978cited by this paper
• Lipid metabolism in cultured cells. Synthesis of vasoactive thromboxane A2 from [14C]arachidonic acid culture lung fibroblasts.

  1978cited by this paper
• Inhibition of platelet prostaglandin synthetase by oral aspirin.

  1978cited by this paper
• Metabolism of thromboxane B2 in the monkey.

  1978cited by this paper
• Stimulation of the release of prostaglandins from polymorphonuclear leukocytes by the calcium ionophore A23187

  1978cited by this paper
• Transformation of arachidonic acid into thromboxane B2 by the homogenates of activated macrophages.

  1978cited by this paper
• Metabolism of prostacyclin in blood vessels.

  1978cited by this paper
• 9,11-Epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human platelets

  1978cited by this paper
• Thromboxane A2 biosynthesis in human lung fibroblasts WI-38.

  1978cited by this paper
• Effects of indomethacin and sulfinpyrazone on in vivo formation of thromboxane B2 and prostaglandin D2 during arachidonate infusion in rabbits.

  1978cited by this paper
• Studies of the mechanisms involved in the fate of prostacyclin (PGI2) and 6-keto-PGF1alpha in the pulmonary circulation.

  1978cited by this paper
• Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.

  1978cited by this paper
• Hereditary abnormality of platelet aggregation attributable to nucleotide storage pool deficiency.

  1978cited by this paper
• Localisation and stimulation of prostacyclin production in vascular cells

  1978cited by this paper
• Enzymatic conversion of prostaglandin endoperoxide H2 and arachidonic acid to prostacyclin by cultured human endothelial cells.

  1978cited by this paper
• PHOSPHOLIPASE A2 ACTIVITY OF GUINEA‐PIG ISOLATED PERFUSED LUNGS: STIMULATION, AND INHIBITION BY ANTI‐INFLAMMATORY STEROIDS

  1978cited by this paper
• EFFECTS OF SULPHINPYRAZONE AND ASPIRIN ON PROSTAGLANDIN I2 (PROSTACYCLIN) SYNTHESIS BY ENDOTHELIAL CELLS

  1978cited by this paper
• Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles.

  1978cited by this paper
• Antibodies which antagonise the effects of prostacyclin

  1978cited by this paper
• Selective antagonism of prostaglandin (PG) E1, PGD2 and prostacyclin (PGI2) on human and rabbit platelets by di-4-phloretin phosphate (DPP).

  1978cited by this paper
• Vascular actions of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog.

  1978cited by this paper
• Solubilization and partial purification of prostaglandin endoperoxide synthetase of rabbit kidney medulla.

  1978cited by this paper
• Preservation of platelet number and function with prostaglandin E1 during total cardiopulmonary bypass in rhesus monkeys.

  1978cited by this paper
• Biosynthesis of thromboxane B2 and 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets. Evidence for a common enzymatic pathway.

  1978cited by this paper
• Ionophore A-23187- and thrombin-induced platelet aggregation: independence from cycloxygenase products.

  1978cited by this paper
• Platelet resistance to prostaglandin D2 in patients with myeloproliferative disorders.

  1978cited by this paper
• Sensitivity of fatty acid cyclooxygenase from human aorta to acetylation by aspirin.

  1978cited by this paper
• Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?

  1978cited by this paper
• Inhibition of prostaglandin biosynthesis by corticosteroids requires RNA and protein synthesis

  1978cited by this paper
• 1-phenyl-3-pyrazolidone: an inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets.

  1978cited by this paper
• Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity.

  1978cited by this paper
• Regional differences in prostacyclin formation by the kidney. Prostacyclin is a major prostaglandin of renal cortex.

  1978cited by this paper
• Metabolism of prostacyclin in rat.

  1978cited by this paper
• Effect of aspirin on thrombin-induced adherence of platelets to cultured cells from the blood vessel wall.

  1978cited by this paper
• Distribution of prostaglandin biosynthetic pathways in organs and tissues of the fetal lamb.

  1978cited by this paper
• Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.

  1978cited by this paper
• Prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. Inactivation and activation by heme and other metalloporphyrins.

  1978cited by this paper
• Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.

  1978cited by this paper
• Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina.

  1978cited by this paper
• Selective inhibition of platelet n-8 lipoxygenase by 5,8,11-eicosatriynoic acid.

  1977cited by this paper
• Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion

  1977cited by this paper
• Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets.

  1977cited by this paper
• Synergism between platelet aggregating agents: the role of the arachidonate pathway.

  1977cited by this paper
• Synthesis of prostaglandin D2 and thromboxane B2 by human platelets.

  1977cited by this paper
• Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid.

  1977cited by this paper
• Metabolism of prostaglandin endoperoxide in animal tissues.

  1977cited by this paper
• High affinity binding of thrombin to platelets. Inhibition by tetranitromethane and heparin.

  1977cited by this paper
• Mechanistic studies on the biosynthesis of 6-ketoprostaglandin F1alpha.

  1977cited by this paper
• Lack of covalent modification of prostaglandin synthetase (cyclo-oxygenase) by indomethacin.

  1977cited by this paper
• Modulation of human platelet adenylate cyclase by prostacyclin (PGX).

  1977cited by this paper
• A novel prostaglandin is the major product of arachidonic acid metabolism in rabbit heart.

  1977cited by this paper
• The mobilization of arachidonic acid in platelets exposed to thrombin or ionophore A23187. Effects of adenosine triphosphate deprivation.

  1977cited by this paper
• Thrombin-Stimulated Myosin Phosphorylation in Intact Platelets and its Possible Involvement Secretion

  1977cited by this paper
• Discrimination between platelet prostaglandin receptors with a specific antagonist of bisenoic prostaglandins.

  1977cited by this paper
• Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets.

  1977cited by this paper
• Identification of the major urinary metabolites of 6-ketoprostaglandin F1alpha (6K-PGF1alpha) in the rat.

  1977cited by this paper
• Effect of organic sulfur compounds on the chemical and enzymatic transformations of prostaglandin endoperoxide H2.

  1977cited by this paper
• Initiation of phospholipase A2 activity in human platelets by the calcium ion ionophore A23187.

  1977cited by this paper
• A particulate arachidonate lipoxygenase in human blood platelets.

  1977cited by this paper
• THE DISTRIBUTION AND METABOLISM OF ARACHIDONIC ACID IN RABBIT PLATELETS DURING AGGREGATION AND ITS MODIFICATION BY DRUGS

  1977cited by this paper
• Metabolism of thromboxane B2 in the cynomolgus monkey.

  1977cited by this paper
• Cyclic adenosine 3',5'-monophosphate and prostacyclin inhibit membrane phospholipase activity in platelets.

  1977cited by this paper
• Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.

  1977cited by this paper
• Solubilization and resolution of thromboxane synthesizing system from microsomes of bovine blood platelets.

  1977cited by this paper
• Characterization of a novel metabolic pathway of arachidonate in coronary arteries which generates a potent endogenous coronary vasodilator.

  1977cited by this paper

• Platelets and Hemostasis

  2018cites this paper
• Ebola Outbreak in West Africa; Is Selenium Involved?

  2016cites this paper
• Pharmacogenomic and clinical data link non-pharmacokinetic metabolic dysregulation to drug side effect pathogenesis

  2015cites this paper
• human platelet function The effect of pharmacologic inhibition of phospholipid methylation on

  2011cites this paper
• Prostaglandins and platelet aggregation.

  2009cites this paper
• Balloon Catheter as a Model of Cerebral Emboli in Humans

  2008cites this paper
• Computational genomic analysis of hemorrhagic fever viruses

  2007cites this paper
• COX-2 inhibitors and cardiovascular risk.

  2007cites this paper
• Prostaglandins and the lung

  2007cites this paper
• Alterations in articular chondrocyte growth and proteoglycan synthesis due to prostanoid precursors

  2004cites this paper
• Synergistic effect of D-003 and aspirin on experimental thrombosis models.

  2003cites this paper
• The influence of antioxidant nutrients on platelet function in healthy volunteers.

  1997cites this paper
• Computational genomic analysis of hemorrhagic fever viruses. Viral selenoproteins as a potential factor in pathogenesis.

  1997cites this paper
• Isradipine increases vascular prostaglandin I2-formation while the thromboxane B2-synthesis is diminished.

  1995cites this paper
• Effects of age on the pharmacodynamics of naproxen in the rat.

  1995cites this paper
• What is the Role of Hysteroscopy in the Management of Abnormal Uterine Bleeding?

  1995cites this paper
• A review--role of eicosanoids in vertebrate ovulation.

  1993cites this paper
• Chapter 3 Mechanisms of thrombus formation and dissolution

  1993cites this paper
• Effects of 9, 12, 15-octadecatrien-6-ynoic acid on the metabolism of arachidonic acid in platelets and on platelet aggregation.

  1992cites this paper
• Chemical Agents That Inhibit Platelet Aggregation

  1992cites this paper
• Prostanoids and Menorrhagia

  1992cites this paper
• Modulation of the platelet thromboxane A2 and aortic prostacyclin synthesis by dietary selenium and vitamin E

  1992cites this paper
• Prostaglandins and lschemic Heart Disease

  1991cites this paper
• 10 Lipids and thrombosis

  1990cites this paper
• Human menstruation and eicosanoids.

  1990cites this paper
• Lipids and thrombosis.

  1990cites this paper
• 8 Heavy, painful periods

  1989cites this paper
• 1 Menstrual disorders—an overview

  1989cites this paper
• Heavy, painful periods.

  1989cites this paper
• Menstrual disorders--an overview.

  1989cites this paper
• Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle. 14-Hydroxy from 22:6n-3 is more potent than 12-HETE.

  1988cites this paper
• Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function.

  1988cites this paper
• Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status.

  1988cites this paper
• Beneficial effects of prostacyclin in a rabbit endotoxin shock model.

  1988cites this paper
• Photochemically Induced Vascular Thrombosis (Photothrombosis): Central Nervous System Consequences and Clinical Possibilities

  1988cites this paper
• Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes mellitus.

  1987cites this paper
• Ethanol-induced alterations in human erythrocyte shape and surface properties: Modulatory role of prostaglandin E1

  1987cites this paper
• Evidence that in vivo constriction of cerebral arterioles by local application of tert-butyl hydroperoxide is mediated by release of endogenous thromboxane.

  1987cites this paper
• Thromboxane biosynthesis and its inhibition in man

  1987cites this paper
• Evolution of Thrombosis

  1987cites this paper
• Oxygen radicals in cell injury and cell death.

  1987cites this paper
• Platelet activation--an overview.

  1987cites this paper
• A pharmacological approach to thromboxane receptor antagonism.

  1987cites this paper
• Lipids in platelet function: platelet and vascular prostaglandins in thromboembolic disease.

  1987cites this paper
• African swine fever. II. Functional disturbances of thrombocytes in pigs infected with virulent haemadsorbing and non-haemadsorbing virus isolates.

  1987cites this paper
• In vivo anti-platelet properties of anipamil, a calcium channel blocker, in the rabbit.

  1986cites this paper
• Infarct Size Reduction: A Review of the Clinical Trials

  1986cites this paper
• Platelet Fibrinogen Binding in Diabetes Mellitus: Differences Between Binding to Platelets from Nonretinopathic and Retinopathic Diabetic Patients

  1986cites this paper
• Eicosenoid biosynthesis and platelet function with advancing age.

  1986cites this paper
• Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.

  1986cites this paper
• Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548).

  1986cites this paper
• Increased Fibrinogen Binding to Platelets from Patients with Familial Hypercholesterolemia

  1986cites this paper
• Angiotensin delays platelet aggregation after injury of cerebral arterioles.

  1986cites this paper
• Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.

  1986cites this paper
• Prostaglandin D2 release by endometrium and myometrium

  1986cites this paper
• Effect of Indomethacin and Dazoxiben on Intravascular Platelet Aggregation in the Anaesthetized Rabbit

  1986cites this paper
• Cancer and the prostaglandins: a mini review on cancer research.

  1985cites this paper
• Enhancement of eicosaenoic acid lipoxygenation in human platelets by 12-hydroperoxy derivative of arachidonic acid

  1985cites this paper
• Disaggregation and reaggregation of ‘irreversibly’ aggregated platelets: A method for more complete evaluation of anti-platelet drugs

  1985cites this paper
• In vivo production of thromboxane in acute human myocardial infarction: a preliminary study.

  1985cites this paper
• Metabolism of arachidonic acid by macaque platelets. Implications for studies on atherosclerosis.

  1985cites this paper
• Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis.

  1985cites this paper
• Blockade of Thromboxane and the Prevention of Eicosanoid-Induced Sudden Death in Mice 1

  1985cites this paper
• Membrane receptors for fibrinogen and factor VIII and abnormalities of platelet function. A review.

  1985cites this paper
• Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids.

  1985cites this paper
• Antithrombotic Therapy in Ischemic Cerebrovascular Disease

  1985cites this paper
• Formation and Role of Lipoxygenase Products in Human Platelets

  1985cites this paper
• Mechanisms of Chemotactic Factor Stimulation of Polymorphonuclear Leukocytes: Modulation by Prostaglandins

  1985cites this paper
• Effects of Prostaglandins on In Vivo Immune and Inflammatory Reactions

  1985cites this paper
• Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets.

  1984cites this paper
• Arachidonate metabolism during chondrogenesisin vitro

  1984cites this paper
• Gerinnungsstörungen im Schock

  1984cites this paper
• Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.

  1984cites this paper
• Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.

  1984cites this paper
• Prostaglandins in human disease.

  1984cites this paper
• Evidence for isosorbide dinitrate (ISDN) promoting effect on prostacyclin release by the lung and prostacyclin implication in ISDN-induced inhibition of platelet aggregation in humans.

  1984cites this paper
• Subcellular localization and some properties of lipoxygenase activity in human blood platelets.

  1984cites this paper
• Development of a gas chromatographic-mass spectrometric method using a stable isotope internal standard for quantitation of thromboxane B2.

  1984cites this paper
• Aspirin in the Prevention of Myocardial Infarction Current Status

  1984cites this paper
• Some properties of mouse platelets.

  1983cites this paper
• Platelet activation during steady state sickle cell disease.

  1983cites this paper
• The possible roles of prostaglandins and related compounds in endometrial bleeding. A mini-review.

  1983cites this paper
• Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system.

  1983cites this paper
• The role of ADP secretion and thromboxane synthesis in factor VIII binding to platelets.

  1983cites this paper
• Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system

  1983cites this paper
• Modulation of equine platelet function by diethylcarbamazine (DEC).

  1983cites this paper
• Effect of OKY-1581, a Thromboxane Synthesis Inhibitor, on the Platelet Aggregation and Vasodilation Induced by Injury of Mouse Pial Arterioles

  1983influential citation
• DIMETHYL SULFOXIDE EFFECTS ON PLATELET AGGREGATION AND VASCULAR REACTIVITY IN PIAL MICROCIRCULATION *

  1983cites this paper
• Sodium 5-(3'-pyridinylmethyl)benzofuran-2-carboxylate (U-63557A), a new, selective thromboxane synthase inhibitor: intravenous and oral pharmacokinetics in dogs and correlations with ex situ thromboxane B2 production.

  1983cites this paper
• Forskolin: A potential antimetastatic agent

  1983cites this paper
• Thromboxane a2: biosynthesis and effects on platelets.

  1982cites this paper
• Binding of platelets to human monocytes: a source of artifacts in the study of the specificity of antileukocyte antibodies.

  1982cites this paper
• Changes in thromboxane B2 and 6-keto-PGF1 alpha after direct electrical stimulation of the denervated rat gastrocnemius1,2.

  1982cites this paper
• Effect of fasting on production from exogenous arachidonic acid of thromboxane and 12-hydroxy 5, 8, 10, 14-Eicosatetraenoic acid (12-HETE) by washed platelets of normal and streptozotocin diabetic mice.

  1982cites this paper
• Unsaturated fatty acids and cyclooxygenase inhibitors: effects on pial arterioles.

  1982cites this paper
• Arachidonic acid protection of rat gastric mucosa against ethanol injury.

  1982cites this paper
• Alterations in the Coagulation System

  1982cites this paper
• Chapter 9. Antithrombotic Agents

  1982cites this paper
• ANTIPLATELET AGENTS: THEIR ROLE IN THE PREVENTION OF SUDDEN DEATH

  1982cites this paper
• Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides.

  1982cites this paper